Drug
Pravafen
Pravafen: highest development phase Phase 3, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pravafen NCT00459745 | Phase 3 | Combined Hyperlipidemia |
Latest
No recent events.
Follow Pravafen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.